Liver Diseases  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00142467: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Completed
2
33
US
Gemcitabine, Gemzar, Oxaliplatin, Eloxatin, Bevacizumab, Avastin
Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Genentech, Inc., Sanofi-Synthelabo, Eli Lilly and Company
Hepatocellular Carcinoma
08/06
06/11
NCT00280618: Oxaliplatin in Unresectable Hepatocellular Carcinoma

Completed
2
RoW
Oxaliplatin
Sanofi
Carcinoma, Hepatocellular
11/06
 
NCT00508872: Folfox-B Study for Patients With Colorectal Liver Metastases

Terminated
2
2
US
5-Fluorouracil, 5-FU, Adrucil, Efudex, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAb-VEGF, Leucovorin, Citrovorum, Wellcovorin, Oxaliplatin, Eloxatin
M.D. Anderson Cancer Center, Sanofi
Colorectal Liver Metastases
06/09
06/09
NCT00559455: Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma

Completed
2
38
RoW
Oxaliplatin, Fluorouracil, Leucovorin
Sanofi
Carcinoma, Hepatocellular
01/10
01/10
NCT00483405: Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer

Checkmark P2 data
Nov 2011 - Nov 2011: P2 data
Completed
2
33
US
cetuximab, Erbitux, capecitabine, Xeloda, oxaliplatin, Eloxatin
UNC Lineberger Comprehensive Cancer Center, Sanofi, Roche Pharma AG, Bristol-Myers Squibb, National Center for Research Resources (NCRR), National Cancer Institute (NCI)
Liver Cancer
02/10
12/10
HEARTO, NCT01348412: Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Completed
2
31
Europe
oxaliplatin, raltitrexed, other intravenous chemotherapy drugs
Centre Georges Francois Leclerc, National Cancer Institute, France, Hospira, now a wholly owned subsidiary of Pfizer
Colorectal Cancer, Liver Metastases
12/10
04/18
BOS2, NCT01508000 / 2010-019238-29: Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Checkmark For wild-type RAS mutant 1st-line mCRC
Jun 2013 - Jun 2013: For wild-type RAS mutant 1st-line mCRC
Terminated
2
44
Europe
FOLFOX6, Chemotherapy, Bevacizumab, Avastin, Panitumumab, Vectibix, Surgery
European Organisation for Research and Treatment of Cancer - EORTC, Amgen, Roche Pharma AG
Colorectal Cancer Metastatic, Liver Metastases, KRAS Wild Type Colorectal Cancer
09/16
09/16
PACOX, NCT02089633: Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC

Completed
2
17
RoW
PACOX, PEG-BCT-100, Xeloda, Eloxatin
Bio-Cancer Treatment International Limited, The University of Hong Kong
Hepatocellular Carcinoma
09/16
10/16

Download Options